Cannabinoid hyperemesis: A case series of 98 patients

Mayo Clinic Proceedings

Volumn 87, Issue 2, 2012, Pages 114-119

  Simonetto, Douglas A ^a   Oxentenko, Amy S ^a   Herman, Margot L ^a   Szostek, Jason H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CANNABINOID HYPEREMESIS; CANNABIS SMOKING; CASE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYDROTHERAPY; MAJOR CLINICAL STUDY; MALE; VOMITING;

EID: 84856642653     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2011.10.005     Document Type: Article

References (25)

1. Leggett T; United Nations Office on Drugs and Crime. A review of the world cannabis situation. Bull Narc. 2006;58(1- 2):1-155.
2. Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7):e141.
3. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566-1570. (Pubitemid 39434095)
4. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76-78.
5. Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. Clin Gastroenterol Hepatol. 2008;6(6):710-712.
6. Donnino MW, Cocchi MN, Miller J, Fisher J. Cannabinoid hyperemesis: a case series. J Emerg Med. 2011;40(4):e63-e66.
7. Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an under- recognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15(10):1264-1266.
8. Soriano-Co M, Batke M, Cappell MS. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States. Dig Dis Sci. 2010;55(11):3113-3119.
9. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Australas Psychiatry. 2007; 15(2):156-158. (Pubitemid 46705812)
10. Watts M. Cannabinoid hyperemesis presenting to a New Zealand hospital. N Z Med J. 2009;122(1290):116-118.
11. Catto-Smith AG, Ranuh R. Abdominal migraine and cyclical vomiting. Semin Pediatr Surg. 2003;12(4):254-258. (Pubitemid 38010142)
12. Li BU, Fleisher DR. Cyclic vomiting syndrome: features to be explained by a pathophysiologic model. Dig Dis Sci. 1999;44(8, suppl):13S-18S. (Pubitemid 29450785)
13. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC. Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. Drug Alcohol Depend. 2007;90(2- 3):210-223.
14. Fleisher DR, Matar M. The cyclic vomiting syndrome: a report of 71 cases and literature review. J Pediatr Gastroenterol Nutr. 1993;17(4):361-369. (Pubitemid 24003012)
15. Walsh D, Nelson KA, Mahmoud FA. Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer. 2003;11(3):137-143. (Pubitemid 36733806)
16. Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs. 2003;17(3):179-202. (Pubitemid 36286534)
17. González S, Cebeira M, Fernández-Ruiz J. Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav. 2005;81(2):300-318. (Pubitemid 40807129)
18. Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010; 126(1):21-38.
19. Storr MA, Sharkey KA. The endocannabinoid system and gut-brain signalling. Curr Opin Pharmacol. 2007;7(6):575-582. (Pubitemid 350177551)
20. Wenger T, Moldrich G. The role of endocannabinoids in the hypothalamic regulation of visceral function. Prostaglandins Leukot Essent Fatty Acids. 2002;66(2-3):301-307. (Pubitemid 34743603)
21. Taché Y. Cyclic vomiting syndrome: the corticotropin-releasing- factor hypothesis. Dig Dis Sci. 1999;44(8, suppl):79S-86S. (Pubitemid 29450796)
22. Hayakawa K, Mishima K, Nozako M, et al. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic- independent hypothermia. Life Sci. 2007;80(16): 1466-1471. (Pubitemid 46399748)
23. Sim-Selley LJ. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol. 2003;15(2):91-119. (Pubitemid 38160440)
24. Hasler WL. Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin North Am. 2007;36(3):619-647, ix. (Pubitemid 47575839)
25. Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend. 2009; 105(1-2):24-32.